Shares of Medical Properties Trust, Inc. (NYSE:MPW - Get Rating) have been given a consensus recommendation of "Moderate Buy" by the thirteen analysts that are covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $16.09.
→ My #1 EV Stock (NOT Tesla) (From Oxford Club)
A number of research analysts have weighed in on the company. Bank of America upgraded Medical Properties Trust from a "neutral" rating to a "buy" rating and raised their price objective for the company from $13.00 to $16.00 in a report on Monday, November 14th. They noted that the move was a valuation call. KeyCorp reduced their price objective on Medical Properties Trust from $18.00 to $16.00 and set an "overweight" rating for the company in a research note on Thursday, January 19th. Barclays cut their price target on Medical Properties Trust from $17.00 to $14.00 and set an "overweight" rating for the company in a research note on Monday. Credit Suisse Group cut their price target on Medical Properties Trust from $13.00 to $11.00 and set a "neutral" rating for the company in a research note on Friday, February 24th. Finally, Mizuho dropped their price objective on Medical Properties Trust from $20.00 to $18.00 in a report on Friday, December 2nd.
Large investors have recently modified their holdings of the stock. Marshall Wace LLP grew its stake in Medical Properties Trust by 348.8% during the 3rd quarter. Marshall Wace LLP now owns 7,104,051 shares of the real estate investment trust's stock valued at $84,256,000 after purchasing an additional 5,521,226 shares in the last quarter. State Street Corp lifted its holdings in shares of Medical Properties Trust by 11.7% in the 1st quarter. State Street Corp now owns 36,158,910 shares of the real estate investment trust's stock worth $774,593,000 after purchasing an additional 3,800,294 shares during the last quarter. Bank of New York Mellon Corp raised its stake in Medical Properties Trust by 24.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 17,071,940 shares of the real estate investment trust's stock valued at $202,473,000 after acquiring an additional 3,355,195 shares in the last quarter. Norges Bank bought a new stake in Medical Properties Trust during the 4th quarter valued at $34,612,000. Finally, Man Group plc bought a new stake in Medical Properties Trust during the 4th quarter valued at $32,630,000. Institutional investors and hedge funds own 80.31% of the company's stock.
Shares of NYSE MPW opened at $10.07 on Thursday. The stock has a market capitalization of $6.02 billion, a price-to-earnings ratio of 6.71, a PEG ratio of 0.63 and a beta of 0.93. Medical Properties Trust has a 12 month low of $9.87 and a 12 month high of $21.63. The firm's 50 day simple moving average is $12.26 and its 200-day simple moving average is $12.52. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.92 and a quick ratio of 1.98.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 13th. Stockholders of record on Thursday, March 16th will be issued a $0.29 dividend. The ex-dividend date is Wednesday, March 15th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 11.52%. Medical Properties Trust's dividend payout ratio (DPR) is 77.33%.
Medical Properties Trust, Inc is a self-advised real estate investment trust, engages in the investment, acquisition, and development of net-leased healthcare facilities. Its property portfolio includes rehabilitation hospitals, long-term acute care hospitals, ambulatory surgery centers, hospitals for women and children, regional and community hospitals, medical office buildings, and other single-discipline facilities.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Medical Properties Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.
While Medical Properties Trust currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.